# haloperidol decanoate

NDC: 25021-831
Generic name: haloperidol decanoate
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20171115

FDA application: ANDA205241

## Active ingredients

- HALOPERIDOL DECANOATE: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-831"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-831
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b3167043-585f-482f-b8a7-591bc2721bd3